Back Login to subscribe 🔔 Set Alert

NXTS Nexentis Technologies Inc. Common Stock

15 min delay

Loading...

Loading...

Loading...

Loading options…

CALLS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

PUTS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

Loading insider data…

Date	Headline	Sentiment
	Nexentis Technologies Files Prospectus For Offering 2.573M Common Shares On Behalf Of Selling Shareholders	93.08%
	Nexentis Technologies Subsidiary Completes Analysis Of SLC Transport Proteins, Starts Global AI Drug Discovery Initiative With Boltz	81.46%
	Nexentis Technologies shares are trading lower. The company announced signing of an Addendum to the Loan and Partnership Agreement for its Melz solar PV project in Germany.	68.45%
	Nexentis Technologies Amends Its Loan And Partnership Agreement With Solterra Renewable Energy, Other Lenders For Melz Solar Project; Solterra To Make Early Partial Repayments Of ~$147K On Its Part Of Loan, $98K For Sale Of 10% Of Its Profit Rights;	80.97%
	Nexentis Technologies shares are trading lower after the company filed a prospectus for an offering of 410,998 shares at $7.056 per share.	97.09%
	Crude Oil Down Over 1%; US Manufacturing PMI Surges In June	97.43%
	Nexentis Technologies Files Prospectus For Offering 410,998 Common Shares At $7.056/Share	93.12%
	Nexentis Technologies Soars 156% Before Falling 46% After Hours — Here’s Why NXTS Stock Is Trending	96.51%
	Dow Jumps 200 Points; Outdoor Holding Shares Fall After Q4 Results	97.34%
	Nexentis Technologies shares are trading higher after the company announced its subsidiary, MitoCareX Bio, entered into an engagement with Boltz for the identification of novel small-molecule scaffolds targeting selected solute carrier proteins of interest to MitoCareX's pipeline	94.63%

1
2
›